Welcome to LookChem.com Sign In|Join Free

CAS

  • or

141056-56-6

Post Buying Request

141056-56-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

141056-56-6 Usage

Description

2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)tetrahydro-2-hydroxy-, 2-oxide, commonly known as cyclophosphamide, is a synthetic alkylating agent that is widely used in chemotherapy for the treatment of various types of cancer. It is known for its potent anticancer properties and works by interfering with the growth and spread of cancer cells in the body. Cyclophosphamide is typically administered intravenously and is metabolized in the liver to produce its active form.
Used in Cancer Treatment:
Cyclophosphamide is used as a chemotherapy agent for the treatment of various types of cancer, including leukemia, lymphoma, and multiple myeloma. It is effective in inhibiting the growth and spread of cancer cells, making it an important tool in cancer therapy.
Used in Medical Industry:
In the medical industry, cyclophosphamide is used as an anticancer drug to treat a wide range of malignancies. Its potent anticancer properties make it a valuable component in the development of cancer treatment protocols.
However, it is important to note that cyclophosphamide can also have significant side effects, such as damage to the bone marrow, leading to a decrease in white blood cells, red blood cells, and platelets. Additionally, it can cause damage to the bladder, resulting in inflammation and hemorrhagic cystitis. Therefore, it is crucial to carefully monitor patients receiving this treatment and manage any side effects that may arise.

Check Digit Verification of cas no

The CAS Registry Mumber 141056-56-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,1,0,5 and 6 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 141056-56:
(8*1)+(7*4)+(6*1)+(5*0)+(4*5)+(3*6)+(2*5)+(1*6)=96
96 % 10 = 6
So 141056-56-6 is a valid CAS Registry Number.

141056-56-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-hydroxy-2-oxo-3-(2-chloroethyl)-1,3,2-oxazaphosphorine

1.2 Other means of identification

Product number -
Other names 3-(2-Chloro-ethyl)-2-oxo-2λ5-[1,3,2]oxazaphosphinan-2-ol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:141056-56-6 SDS

141056-56-6Downstream Products

141056-56-6Relevant articles and documents

Chemical stability and fate of the cytostatic drug ifosfamide and its N- dechloroethylated metabolites in acidic aqueous solutions

Gilard, Véronique,Martino, Robert,Malet-Martino, Myriam,Niemeyer, Ulf,Pohl, J?rg

, p. 2542 - 2560 (2007/10/03)

31P NMR spectroscopy was used to study the products of the decomposition of the antitumor drug ifosfamide (IF, 1d) and its N- dechloroethylated metabolites, namely, 2,3-didechloroethylIF (1a) and 2- (1b) and 3-dechloroethylIF (1c), in buffered solutions at acidic pH. The first stage of acid hydrolysis of these four oxazaphosphorines is a P-N bond cleavage of the six-membered ring leading to the phosphoramidic acid monoesters (2a-d) of type R'HN(CH2)3OP(O)(OH)-NHR, with R and/or R' = H or (CH2)2Cl. The electron-withdrawing chloroethyl group at the endocyclic and/or exocyclic nitrogens counteracts the endocyclic P-N bond hydrolysis. This effect is even more marked when the N-chloroethyl group is in the exocyclic position since the order of stability is 1d > 1c > 1b > 1a. In the second stage of hydrolysis, the remaining P-N bond is cleaved together with an intramolecular attack at the phosphorus atom by the non-P-linked nitrogen of the compounds 2a-d. This leads to the formation of a 2- hydroxyoxazaphosphorine ring with R = H (3a coming from compounds 2a,c) or (CH2)2Cl (3b coming from compounds 2b,d) and to the release of ammonia or chloroethylamine. The third step is the P-N ring opening of the oxazaphosphorines 3a,b leading to the phosphoric acid monoesters, H2N(CH2)3OP(O)(OH)2 (4a) and Cl(CH2)2HN(CH2)3OP(O)(OH)2 (4b-1), respectively. For the latter compound, the chloroethyl group is partially (at pH 5.5) or totally (at pH 7.0) cyclized into aziridine (4b-2), which is then progressively hydrolyzed into an N-hydroxyethyl group (4b-3). Compounds 3a,b are transient intermediates, which in strongly acidic medium are not observed with 31P NMR. In this case, cleavage of the P-N bond of the type 2 phosphoramidic acid monoesters leads directly to the type 4 phosphoric acid monoesters. The phosphate anion, derived from P-O bond cleavage of these latter compounds, is only observed at low levels after a long period of hydrolysis. Compounds 1a-c and some of their hydrolytic degradation products (4b-1, 4b-2, diphosphoric diester [Cl(CH2)2NH(CH2)3OP(O)(OH)]2O (5), and chloroethylamine) did not exhibit, as expected, any antitumor efficacy in vivo against P388 leukemia. 31P NMR determination of the N- dechloroethylated metabolites of IF or its structural isomer, cyclophosphamide (CP), and their degradation compounds could provide an indirect and accurate estimation of chloroacetaldehyde amounts formed from CP or IF.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 141056-56-6